A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors

Clinical trial NCT06043466 · RECRUITING

Trial details

NCT number: NCT06043466
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Esophagus Cancer Gastric Cancer Pancreas Cancer Non-small Cell Lung Cancer Breast Cancer Bile Duct Cancer

Start date: 2023-08-11
Primary completion: 2026-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.